Table 3.
Normal weight BMI: 18.5–24.9 (N = 50) | Overweight BMI: 25.0 – 29.9 (N = 62) | Obese BMI >= 30 (N = 133) | P-value* | |
---|---|---|---|---|
Demographics | ||||
Age (yrs) | 40 (14) | 41 (14) | 43 (13) | 0.34 |
Female, N (%) | 35 (70%) | 40 (65%) | 96 (72%) | 0.54 |
Race, N (%) | 0.81 | |||
White | 29 (58%) | 34 (55%) | 64 (48%) | |
Black | 17 (34%) | 23 (37%) | 56 (42%) | |
Other | 4 (8%) | 5 (8%) | 13 (10%) | |
Lung function | ||||
FEV1 % predicted | 76.5 (16.7) | 78.5 (14.1) | 78.0 (16.5) | 0.95 |
FVC % predicted | 90.8 (16.6) | 91.2 (14.9) | 85.4 (15.5) | 0.02 |
FEV1/FVC | 84.6 (13.7) | 86.7 (11.1) | 91.4 (10.3) | 0.002 |
Asthma severity | ||||
JAC | 2.22 (0.80) | 2.06 (0.68) | 2.35 (0.79) | 0.13 |
ASUI | 0.78 (0.66 to 0.85) | 0.79 (0.74 to 0.89) | 0.71 (0.55 to 0.84) | 0.049 |
OSA characteristics | ||||
Sleep apnea, N (%)+ | 0 (0%) | 4 (6%) | 23 (17%) | < 0.001 |
Snoring, N (%)‡ | 25 (50%) | 41 (66%) | 107 (80%) | < 0.001 |
Witnessed apneas, N (%)‡‡ | 3 (6%) | 8 (13%) | 29 (22%) | 0.02 |
Day time naps, N (%)‡¶ | 12 (24%) | 12 (19%) | 48 (36%) | 0.04 |
CPAP/BIPAP use, N (%) | 0 (0%) | 1 (2%) | 8 (6%) | 0.12 |
p value reported for Kruskal-Wallis test for continuous variables, and Fisher’s exact test for proportions
participants responded yes/no to the question “Have you ever been diagnosed with sleep apnea?”
participants participants responded yes/no to the question “Have you ever been told you snore?”
participants responded yes/no to the question “Has anyone ever noticed that you stop breathing during your sleep?”
Participants responded yes/no to the question “Do you often take naps during the day?”